Laboratory News and Research

RSS

UNC researchers look to NGS for better understanding of COVID-19

It might be the future of diagnostic testing for common infections, and could prove to be a crucial tool for understanding and fighting novel viruses.

23 Mar 2020

The COVID-19 vaccine pipeline

Major nations are in a race to make an effective vaccine that could help treat the novel coronavirus infection COVID-19. As hundreds of thousands are infected across the world and over sixteen thousand killed, the pandemic shows no signs of relenting.

23 Mar 2020

OncoMX knowledgebase improves exploration of cancer biomarkers and related evidence

The OncoMX knowledgebase will improve the exploration and research of cancer biomarkers in the context of related evidence, according to a recent article from the George Washington University.

23 Mar 2020

UniTrento played prominent role in proposing ultrasound diagnosis to tackle coronavirus

The article presents the results of the diagnostic protocol for Covid-19 that Libertario Demi developed with a dozen Italian clinical teams that are working very hard in emergency settings.

23 Mar 2020

Scientists discover new genetic editing powers in squid

Revealing yet another super-power in the skillful squid, scientists have discovered that squid massively edit their own genetic instructions not only within the nucleus of their neurons, but also within the axon -- the long, slender neural projections that transmit electrical impulses to other neurons.

23 Mar 2020

Wasan lab develops novel oral formulation to treat systemic fungal infections

The Wasan Laboratory in the Faculty of Pharmaceutical Sciences at the University of British Columbia in partnership with iCo Therapeutics Inc. (Vancouver BC, Canada) have developed a novel oral formulation of Amphotericin B to treat systemic fungal and parasitic infections.

23 Mar 2020

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

James Diaz, MD, MHA, MPH & TM, Dr PH, Professor and Head of Environmental Health Sciences at LSU Health New Orleans School of Public Health, has proposed a possible explanation for the severe lung complications being seen in some people diagnosed with COVID-19.

23 Mar 2020

Tiny device can rapidly detect harmful bacteria in blood

Engineers have created a tiny device that can rapidly detect harmful bacteria in blood, allowing health care professionals to pinpoint the cause of potentially deadly infections and fight them with drugs.

23 Mar 2020

University of Queensland race to accelerate COVID-19 vaccine research

A funding injection of up to $17 million for vital University of Queensland research could help cut the timeline for an effective vaccine for COVID-19 by six months.

22 Mar 2020

Coronavirus remains for several hours to days on surfaces and in aerosols, study reveals

The virus that causes COVID-19 remains for several hours to days on surfaces and in aerosols, a new study published in the New England Journal of Medicine found.

22 Mar 2020

UC San Diego partners with five leading diagnostics manufacturers to ramp up testing for COVID-19

Partnering with five leading in vitro diagnostics manufacturers, an interdisciplinary team of scientists and physicians at UC San Diego Health and University of California San Diego School of Medicine today announced that the UC San Diego Center for Advanced Laboratory Medicine is significantly ramping up testing for COVID-19, projecting a capacity to complete 1,000 to 1,500 tests per day within two to three weeks.

22 Mar 2020

Tel Aviv University joins volunteer initiative to improve detection of novel coronavirus in Israel

Israeli hospitals and universities, including Tel Aviv University, have joined forces to build an enormous student volunteer base to expand and improve the detection of people infected with novel coronavirus all over Israel.

22 Mar 2020

Plasma monitoring of EGFR mutations in NSCLC may help predict resistance to tyrosine kinase inhibitors

Oncotarget Volume 11, Issue 11 reported that at clinical progression, 64 EGFR T790M plasma positive patients were subjected to second line-treatment with osimertinib and strictly monitored during the first month of therapy.

22 Mar 2020

Study uncovers a new childhood-onset neurodegenerative disorder

A study has uncovered a new neurodegenerative disorder in which children experience developmental regression and severe epilepsy.

21 Mar 2020

DSI alumni use computational design to quickly discover treatments for COVID-19

Two graduates of the Data Science Institute at Columbia University are using computational design to quickly discover treatments for the coronavirus.

21 Mar 2020

Scientists identify new role of important factor in early embryonic development

In collaboration with Stanford University, a working group from MedUni Vienna’s Division of Cell and Developmental Biology, led by Mark Wossidlo, has identified the role of a factor involved in early embryonic development.

20 Mar 2020

Researchers develop accurate and scalable method to record brain activity

A new method to accurately record brain activity at scale has been developed by researchers at the Crick, Stanford University and UCL.

20 Mar 2020

HORIBA Medical’s Yumizen G200 hemostasis device validated for use with UK NEQAS BC samples

HORIBA UK Ltd, Medical announces that a study has shown that UK National External Quality Assessment Scheme for Blood Coagulation external quality assessment lyophilized plasma samples can be tested on its Yumizen G200 hemostasis instrument.

From HORIBA Medical 20 Mar 2020

AI may help predict tumor sensitivity to systemic cancer therapies

Using standard-of-care computed tomography scans in patients with advanced non-small cell lung cancer, researchers utilized artificial intelligence to train algorithms to predict tumor sensitivity to three systemic cancer therapies.

20 Mar 2020

World’s fastest supercomputer identifies chemicals with potential to stop COVID-19

What makes the coronavirus disease (COVID-19) global pandemic different from the Spanish flu in 1918? In 1918, transportation, technology, and science were in their infancy, with the medical field not capable of fighting outbreaks. Technology has come a long way, within days, scientists have already identified the type of virus spreading in China, and three months after, vaccine trials have started.

20 Mar 2020

Laboratory News and Research

UNC researchers look to NGS for better understanding of COVID-19

The COVID-19 vaccine pipeline

OncoMX knowledgebase improves exploration of cancer biomarkers and related evidence

UniTrento played prominent role in proposing ultrasound diagnosis to tackle coronavirus

Scientists discover new genetic editing powers in squid

Wasan lab develops novel oral formulation to treat systemic fungal infections

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

Tiny device can rapidly detect harmful bacteria in blood

University of Queensland race to accelerate COVID-19 vaccine research

Coronavirus remains for several hours to days on surfaces and in aerosols, study reveals

UC San Diego partners with five leading diagnostics manufacturers to ramp up testing for COVID-19

Tel Aviv University joins volunteer initiative to improve detection of novel coronavirus in Israel

Plasma monitoring of EGFR mutations in NSCLC may help predict resistance to tyrosine kinase inhibitors

Study uncovers a new childhood-onset neurodegenerative disorder

DSI alumni use computational design to quickly discover treatments for COVID-19

Scientists identify new role of important factor in early embryonic development

Researchers develop accurate and scalable method to record brain activity

HORIBA Medical’s Yumizen G200 hemostasis device validated for use with UK NEQAS BC samples

AI may help predict tumor sensitivity to systemic cancer therapies

World’s fastest supercomputer identifies chemicals with potential to stop COVID-19

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo